Friday, July 31, 2026

Unveiling 30 Years Later: South Korea and Israel’s Secret Defense Talks on North Korean Arms

Declassified documents reveal South Korea and Israel's 1990s efforts to form a joint task force addressing North Korea's arms exports.

North Korea on Edge as Pyongyang Warns of Torrential Rains and Flood Threats

North Korea issues heavy rain warnings for multiple provinces, urging residents to take safety measures amid potential flooding.

North Korea Holds Nationwide Events to Mark 80th Liberation Anniversary

North Korea commemorates the 80th Liberation Day with events, emphasizing anti-Japanese struggle and dynastic leadership for political legitimacy.

Tag: Cartistem

CARTISTEM vs. Traditional Treatments: What Makes Medipost’s Stem Cell Therapy a Game-Changer?

Medipost to commercialize CARTISTEM in Japan using domestically produced media, enhancing supply chain stability and competitiveness.

Medipost Reports Positive Phase 3 Results for CARTISTEM in Japan’s Knee Osteoarthritis Trial

Medipost's CARTISTEM therapy shows significant efficacy in Phase 3 trials for knee osteoarthritis in Japan, enhancing global competitiveness.

Medipost’s CARTISTEM® Completes Phase 3 Trials in Japan: What This Means for Knee Osteoarthritis Treatment

Medipost completes Phase 3 trial for CARTISTEM in Japan, targeting knee osteoarthritis treatment and planning U.S. trial enrollment soon.

Medipost’s Cartistem: Achieving 3000 Knee Cartilage Restoration Surgeries – A Game Changer for Osteoarthritis Treatment

Medipost's Cartistem therapy reaches 3,000 procedures for cartilage restoration, proving its safety and efficacy for knee osteoarthritis.

U.S. Surgeons Get Hands-On With Korea’s Game-Changing Stem Cell Therapy

Medipost's Cartistem® training program for U.S. orthopedic specialists enhances global collaboration and prepares for Phase 3 trials.

Top News

- Our Sponsors Ad -

Follow us